Pulse Biosciences (Nasdaq:PLSE) announced today that it appointed Liane Teplitsky as its new COO to further bolster its leadership team. Hayward, California-based Pulse Biosciences also expanded the role of Dr. David Kenigsberg to full-time chief medical officer (CMO). The pulsed field ablation (PFA) technology developer says the appointments … [Read more...] about Pulse Biosciences names Liane Teplitsky as new COO
personnel announcements
PFA tech developer Field Medical names new CEO
Field Medical announced today that it named Dr. Mark A. Turco as CEO, effective immediately. Turco brings more than 30 years of leadership experience to the pulsed field ablation (PFA) technology developer. It was founded by Dr. Steven Mickelsen, who also serves as chief technology officer. Mickelsen previously founded Farapulse, which Boston … [Read more...] about PFA tech developer Field Medical names new CEO
Procyrion adds former Silk Road Medical exec as new CCO
Procyrion announced today that it appointed Andrew Davis as its new chief commercial officer (CCO), effective immediately. Houston-based Procyrion develops a catheter-deployed percutaneous mechanical circulatory support (pMCS) device called Aortix. The company designed the device to treat patients with acute decompensated heart failure (ADHF) … [Read more...] about Procyrion adds former Silk Road Medical exec as new CCO
Penumbra promotes from within to fill president position
Penumbra (NYSE:PEN) announced today that it promoted Shruthi Narayan to the position of president of the company. Narayan's appointment goes into effect on Sept. 1, 2025. She continues to report to Adam Elsesser, who previously held the post of president before this promotion. Elsesser continues on as the Penumbra's chair and CEO. The … [Read more...] about Penumbra promotes from within to fill president position
Second Heart Assist adds investment firm veteran to board
Second Heart Assist announced that it appointed Bill Carpou to its board of directors as it prepares to scale its cardio-renal platform. Carpou currently serves as CEO of Octane, a leading growth platform for medical technology companies. He previously held a senior operating role with Blackstone, the world's largest alternative investment … [Read more...] about Second Heart Assist adds investment firm veteran to board
InspireMD brings in $58M, adds former Axonics CEO to board
InspireMD (Nasdaq:NSPR) announced today that it raised approximately $58 million and added an experienced executive to its board. In addition to a significant equity private placement (PIPE) financing and warrant exercise, the company appointed Raymond W. Cohen to its board of directors. Cohen brings more than 40 years of leadership experience to … [Read more...] about InspireMD brings in $58M, adds former Axonics CEO to board
Johnson & Johnson MedTech adds new CMO for its Electrophysiology business
Johnson & Johnson MedTech (NYSE: JNJ) announced that it has a new chief medical & scientific officer for its Electrophysiology unit. Michael Bodner, group chair for Electrophysiology & Neurovascular, posted on LinkedIn that the company appointed Dr. Gregory Michaud to the role. Michaud, a globally recognized electrophysiologist, … [Read more...] about Johnson & Johnson MedTech adds new CMO for its Electrophysiology business
Spectrum Vascular bolsters executive team with new CEO, CCO
Spectrum Vascular announced today that it added to its executive team with the appointment of Ken Miller as CEO and Doug Shook as CCO. The company said its leadership appointments help advance its mission to deliver improved patient outcomes and scale impact. They build upon recent momentum, according to a news release, following a strategic … [Read more...] about Spectrum Vascular bolsters executive team with new CEO, CCO
Gradient adds former Edwards exec to board as FDA approves trial expansion
Gradient Denervation Technologies announced today that it appointed medical device entrepreneur and executive Stanton Rowe to its board. Paris-based Gradient also said the FDA approved an expansion of its early feasibility study of its hypertension treatment. The company develops a minimally invasive, ultrasound-based catheter device for … [Read more...] about Gradient adds former Edwards exec to board as FDA approves trial expansion
Zeus has a new catheters GM
NEWS RELEASE: Zeus welcomes new general manager, reinforcing commitment to catheter innovation Orangeburg, South Carolina – Zeus, a world leader in polymer extrusion and catheter manufacturing, is pleased to announce a pivotal addition to its leadership team, reflecting an unwavering commitment to innovation and excellence in providing solutions … [Read more...] about Zeus has a new catheters GM
